Cited by 253Neurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.

The 5-HT7 receptor and disorders of the nervous system: an overview

Open access

Hedlund, Peter B.·2009·Psychopharmacology

DOI 10.1007/s00213-009-1626-0PMC PMC2841472

Open this paper in CoChat — free account

Abstract

Rationale The 5-HT(7) receptor is a more recently discovered G-protein-coupled receptor for serotonin. The functions and possible clinical relevance of this receptor are not yet fully understood.Objective The present paper reviews to what extent the use of animal models of human psychiatric and neurological disorders have implicated the 5-HT(7) receptor in such disorders. The studies have used a combination of pharmacological and genetic tools targeting the receptor to evaluate effects on behavior.Results Models of anxiety and schizophrenia have yielded mixed results with no clear role for the 5-HT(7) receptor described in these disorders. Some data are available for epilepsy, migraine, and pain but it is still very early to draw any definitive conclusions. There is a considerable amount of evidence supporting a role for the 5-HT(7) receptor in depression. Both blockade and inactivation of the receptor have resulted in an antidepressant-like profile in models of depression. Supporting evidence has also been obtained in sleep studies. Especially interesting are the augmented effects achieved by combining antidepressants and 5-HT(7) receptor antagonists. The antidepressant effect of amisulpride has been shown to most likely be mediated by the 5-HT(7) receptor.Conclusions The use of pharmacological and genetic tools in preclinical animal models strongly supports a role for the 5-HT(7) receptor in depression. Indirect evidence exists showing that 5-HT(7) receptor antagonism is clinically useful in the treatment of depression. Available data also indicate a possible involvement of the 5-HT(7) receptor in anxiety, epilepsy, pain, and schizophrenia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00213-009-1626-0

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Major depressive disorder
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“The forced swim test and the tail suspension test are two of the most common behavioral models for evaluating the antidepressant potential of a drug or to evaluate the phenotype of transgenic animals with respect to depression (Cryan et al. 2002; Cryan and Holmes 2005).”
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 1×
“Chronic unpredictable mild stress is a model that attempts to induce a depression-like state in laboratory animals (Willner et al. 1992).”
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S. M., Arrington, E. G., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 982
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms
Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., Foye, P. E., Racke, M. M., Slone, A. L., Siegel, B. W., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90149-l · Cited by 691
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Ruat, M., Traiffort, É., Leurs, R., Tardivel‐Lacombe, J., Díaz, J., Arrang, J., & Schwartz, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 630
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W., & Sibley, D. R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13616-x · Cited by 598
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
Choudhary, M. S., Craigo, S. C., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Bard, J., Zgombick, J. M., Adham, N., VAYSSE, P. J. ‐., Branchek, T. A., & Weinshank, R. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49479-9 · Cited by 533
8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity
Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikstr�m, H., Arvidsson, L. E., Hacksell, U., & Nilsson, J. (1982) · Journal of Neural Transmission · doi:10.1007/bf01276574 · Cited by 515
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Shen, Y., Monsma, F. J., Metcalf, M. A., José, P. A., Hamblin, M. W., & Sibley, D. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46830-x · Cited by 508
Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics
Cohrs, S. (2008) · CNS Drugs · doi:10.2165/00023210-200822110-00004 · Cited by 433
Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes
Lawler, C. P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 410
Functional, molecular and pharmacological advances in 5-HT receptor research
Hedlund, P. B., & Sutcliffe, J. G. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.002 · Cited by 350
Self-citation
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
Abbas, A. I., Hedlund, P. B., Huang, X., Tran, T. B., Meltzer, H. Y., & Roth, B. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1521-8 · Cited by 289
Self-citation
Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist
Hagan, J. J., Price, G. W., Jeffrey, P., Deeks, N. J., Stean, T. O., Piper, D. C., Smith, M. I., Upton, N., Medhurst, A. D., Middlemiss, D. N., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703357 · Cited by 288
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., & Sutcliffe, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.012 · Cited by 281
Self-citation
Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
Berman, R. M., Fava, M., Thase, M. E., Trivedi, M. H., Swanink, R., McQuade, R. D., Carson, W. H., Adson, D., Taylor, L., Hazel, J., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900020216 · Cited by 260
A Novel, Potent, and Selective 5-HT7Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)
Lovell, P. J., Bromidge, S. M., Dabbs, S., Duckworth, D. M., Forbes, I. T., Jennings, A. J., King, F. D., Middlemiss, D. N., Rahman, S. K., Saunders, D. V., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991151j · Cited by 252
A combined marble burying–locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants
Nicolas, L. B., Kolb, Y., & Prinssen, E. P. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.015 · Cited by 234 · cited 1×
“One fairly well-established model for obsessive-compulsive disorder is marble burying, even though several investigators regard this mainly as a model for anxiety (Nicolas et al. 2006).”
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Wesołowska, A., Nikiforuk, A., Stachowicz, K., & Tatarczynska, E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.017 · Cited by 230
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
Guscott, M. R., Bristow, L. J., Hadingham, K. L., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F. A., Owens, A. P., Huscroft, I. T., Myers, J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.015 · Cited by 229
Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors
Dogrul, A. B., Ossipov, M. H., & Porreca, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.001 · Cited by 229
BindingDB Entry 4895: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
BindingDB (2011) · PubMed · doi:10.7270/q2154fjq · Cited by 224
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
Roth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., Monsma, F. J., Shen, Y., Meltzer, H. Y., & Sibley, D. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38596-4 · Cited by 214
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents
Hedlund, P. B., Kelly, L., Mazur, C., Lovenberg, T. W., Sutcliffe, J. G., & Bonaventure, P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.031 · Cited by 192
Self-citation
Obsessive-compulsive disorder
Heyman, I. (2006) · BMJ · doi:10.1136/bmj.333.7565.424 · Cited by 187
5-HT7 Receptors
Thomas, D. W., & Hagan, J. J. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482633 · Cited by 184
No hypothermic response to serotonin in 5-HT 7 receptor knockout mice
Hedlund, P. B., Danielson, P. E., Thomas, E. A., Slanina, K. A., Carson, M. J., & Sutcliffe, J. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337340100 · Cited by 182
Self-citation
Midbrain Raphe Modulation of Nonphotic Circadian Clock Resetting and 5-HT Release in the Mammalian Suprachiasmatic Nucleus
Glass, J. D., Grossman, G. H., Farnbauch, L. A., & DiNardo, L. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07451.2003 · Cited by 176
Elucidation of the neurobiology of depression: insights from a novel genetic animal model
Yadid, G., Nakash, R., Roth‐Deri, I., Tamar, G., Kinor, N., Gispan, I. H., & Zangen, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00018-6 · Cited by 172
Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents
Bonaventure, P., Kelly, L., Aluisio, L. E., Shelton, J. E., Lord, B., Galici, R., Miller, K. L., Atack, J. R., Lovenberg, T. W., & Dugovic, C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119404 · Cited by 170
Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus
Mullins, U. L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00041-x · Cited by 166
Mice lacking 5‐HT7 receptors show specific impairments in contextual learning
Roberts, A. J., Krucker, T., Levy, C. L., Slanina, K. A., Sutcliffe, J. G., & Hedlund, P. B. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03288.x · Cited by 151
Self-citation
Studies on the neuroendocrine role of serotonin.
Jørgensen, H. S. (2007) · PubMed · Cited by 144
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice
Brenchat, A., Romero, L. I., Garcı́a, M., Pujol, M., Burgueño, J., Torrens, A., Hamon, M., Baeyens, J. M., Buschmann, H., Zamanillo, D., et al. (2009) · Pain · doi:10.1016/j.pain.2008.11.009 · Cited by 142
In Vivo Resetting of the Hamster Circadian Clock by 5-HT7Receptors in the Suprachiasmatic Nucleus
Ehlen, J. C., Grossman, G. H., & Glass, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05351.2001 · Cited by 139
8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production
Sprouse, J. S., Reynolds, L. S., Li, X., Braselton, J. P., & Schmidt, A. W. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.007 · Cited by 137
Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats
Li, Y., Wang, F., Pan, Y., Qiang, L.-Q., Cheng, G. S., Zhang, W., & Kong, L. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.01.006 · Cited by 136
5-HT1-like receptor agonists and the pathophysiology of migraine
Saxena, P. R., & Ferrari, M. D. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90238-1 · Cited by 134
Methylphenidate Administration to Adolescent Rats Determines Plastic Changes on Reward-Related Behavior and Striatal Gene Expression
Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G., & Perrone‐Capano, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300962 · Cited by 133
5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons
Ying, S.-W., & Rusak, B. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00102-9 · Cited by 131
Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: Immunocytochemical evidence
Doly, S., Fischer, J., Brisorgueil, M., Vergé, D., & Conrath, M. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20667 · Cited by 129
SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats
Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P. D., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G. J., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705290 · Cited by 127
The 5-HT7 receptor is involved in allocentric spatial memory information processing
Sarkisyan, G., & Hedlund, P. B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.011 · Cited by 125
Self-citation
Serotonin pharmacology in the gastrointestinal tract: a review
Beattie, D. T., & Smith, J. A. M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0276-9 · Cited by 121
Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia
Pouzet, B., Didriksen, M., & Arnt, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00744-4 · Cited by 120
Amisulpride versus imipramine and placebo in dysthymia and major depression
Lecrubier, Y., Boyer, P., Turjanski, S., & Rein, W. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)00103-6 · Cited by 118
Tetrahydrobenzindoles: Selective Antagonists of the 5-HT7Receptor
Kikuchi, C., Nagaso, H., Hiranuma, T., & Koyama, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980519u · Cited by 118
Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice
Wesołowska, A., Tatarczynska, E., Nikiforuk, A., & Chojnacka-Wójcik, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.001 · Cited by 115
Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats
Wesołowska, A., Nikiforuk, A., & Stachowicz, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.064 · Cited by 112
Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission A double-blind, comparative study
Smeraldi, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00139-0 · Cited by 104
Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test
Rocha-González, H. I., Meneses, A., Carlton, S. M., & Granados‐Soto, V. (2005) · Pain · doi:10.1016/j.pain.2005.06.011 · Cited by 99
Systemic morphine produce antinociception mediated by spinal 5‐HT7, but not 5‐HT1A and 5‐HT2 receptors in the spinal cord
Dogrul, A. B., & Seyrek, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706854 · Cited by 98
Pharmacological evidence for the 5‐HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries
Terrón, J. A., & Falcón‐Neri, A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702580 · Cited by 90
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy
Gráf, M., Jakus, R., Kántor, S., Lévay, G. I., & Bagdy, G. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.072 · Cited by 89
Effect of 5-HT7 antagonist SB-269970 in the modulation of working and reference memory in the rat
Gasbarri, A., Cifariello, A., Pompili, A., & Meneses, A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.020 · Cited by 87
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Hedlund, P. B., & Sutcliffe, J. G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.054 · Cited by 84
Self-citation
Response of the Mouse Circadian System to Serotonin 1A/2/7 Agonists in vivo: Surprisingly Little
Antle, M. C., Ogilvie, M. D., Pickard, G. E., & Mistlberger, R. E. (2003) · Journal of Biological Rhythms · doi:10.1177/0748730403251805 · Cited by 82
The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behavior
Ballaz, S., Akil, H., & Watson, S. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.043 · Cited by 80
Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior
Ballaz, S., Akil, H., & Watson, S. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.024 · Cited by 68
5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT1A receptor stimulation on contextual learning in mice
Eriksson, T. M., Golkar, A., Ekstrom, J. C., Svenningsson, P., & Ögren, S. O. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.026 · Cited by 68
Mediation of 5‐HT‐induced external carotid vasodilatation in GR 127935‐pretreated vagosympathectomized dogs by the putative 5‐HT7 receptor
Villalón, C. M., Centurión, D., Estrada, M. L., Terrón, J. A., & Sánchez‐López, A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701020 · Cited by 68
New light on the serotonergic paradox in the rat circadian system
Cuesta, M., Clesse, D., Pévet, P., & Challet, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06128.x · Cited by 67
Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology
Leo, D., Adriani, W., Cavaliere, C., Cirillo, G., Marco, E. M., Romano, E., di Porzio, U., Papa, M., Perrone‐Capano, C., & Giovanni Laviola, A. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00486.x · Cited by 66
Positive Association of the Serotonin 5-HT7 Receptor Gene with Schizophrenia in a Japanese Population
Ikeda, M., Iwata, N., Kitajima, T., Suzuki, T., Yamanouchi, Y., Kinoshita, Y., & Ozaki, N. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300901 · Cited by 65
Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity
Galici, R., Boggs, J. D., Miller, K. L., Bonaventure, P., & Atack, J. R. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f62d8c · Cited by 64
Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine7 receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with α2 adrenergic receptors
Bonaventure, P., Nepomuceno, D. H., Hein, L., Sutcliffe, J. G., Lovenberg, T. W., & Hedlund, P. B. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.014 · Cited by 64
Self-citation
Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats.
Wesołowska, A., & Kowalska, M. (2008) · PubMed · Cited by 60
An RT-PCR study of 5-HT6 and 5-HT7 receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia
East, S. Z., Burnet, P. W. J., Kerwin, R. W., & Harrison, P. J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00323-1 · Cited by 60
Evidence for the involvement of central 5‐HT7 receptors in the micturition reflex in anaesthetized female rats
Read, K. E., Sanger, G. J., & Ramage, A. G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705399 · Cited by 58
Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation
Harte, S. E., Kender, R. G., & Borszcz, G. S. (2004) · Pain · doi:10.1016/j.pain.2004.11.023 · Cited by 55
Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus
Duncan, M. J., Grear, K. E., & Hoskins, M. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.025 · Cited by 54
Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice
Bourson, A., Kapps, V., Zwingelstein, C., Rudler, A., Boess, F., & Sleight, A. J. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005123 · Cited by 53
Inactivation of the 5-HT7 Receptor Partially Blocks Phencyclidine-Induced Disruption of Prepulse Inhibition
Semenova, S., Geyer, M. A., Sutcliffe, J. G., Markou, A., & Hedlund, P. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.011 · Cited by 53
Self-citation
Circadian Rhythm Phenotype of 5-HT₇ Receptor Knockout Mice: 5-HT and 8-OH-DPAT-Induced Phase Advances of SCN Neuronal Firing
Sprouse, J. S., Li, X., Stock, J. L., McNeish, J. D., & Reynolds, L. S. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730404273432 · Cited by 50
Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds
Witkin, J. M., Baez, M., Yu, J., Barton, M. E., & Shannon, H. E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.03.017 · Cited by 49
5-HT1A/1B, 5-HT6, and 5-HT7 serotonergic receptors recruitment in tonic-clonic seizure-induced antinociception: Role of dorsal raphe nucleus
de Freitas, R. L., Ferreira, C. M. D. R., Urbina, M., Marino, A., Carvalho, A. D., Butera, G., de Oliveira, A. M., & Coimbra, N. C. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.003 · Cited by 40
Presence of a 5-HT7Receptor Positively Coupled to Adenylate Cyclase Activation in Human Granulosa-Lutein Cells1
Graveleau, C., Paust, H., Schmidt-Grimminger, D., & Mukhopadhyay, A. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6448 · Cited by 38
5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats
Terrón, J. A., & Martínez-García, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.019 · Cited by 36
5‐hydroxytryptamine induced relaxation in the pig urinary bladder neck
Recio, P., Barahona, M. V., Orensanz, L. M., Bustamante, S., Martı́nez, A. C., Benedito, S., García‐Sacristán, A., Prieto, D., & Hernández, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00144.x · Cited by 35
Serotonin 5-HT7receptors mediate relaxation of porcine pial veins
Ishine, T., Bouchelet, I., Hamel, É., & Lee, T. J.-F. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.3.h907 · Cited by 33
Antagonism of 5‐HT1Areceptors uncovers an excitatory effect of SSRIs on 5‐HT neuronal activity, an action probably mediated by 5‐HT7receptors
Bosker, F. J., Folgering, J. H. A., Gladkevich, A. V., Schmidt, A. W., van der Hart, M. G. C., Sprouse, J. S., den Boer, J. A., Westerink, B. H. C., & Cremers, T. I. F. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05850.x · Cited by 30
5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor
Shelton, J. E., Bonaventure, P., Li, X., Yun, S., Lovenberg, T. W., & Dugovic, C. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.014 · Cited by 30
Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients
Wei, Z., Wang, L., Xuan, J., Che, R., Du, J., Qin, S., Xing, Y., Gu, B., Yang, L., Li, H., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.008 · Cited by 26
The inhibitory effect of serotonin on the spontaneous discharge of suprachiasmatic neurons in hypothalamic slice is mediated by 5-HT7 receptor
Yu, G.-D., Liu, Y.-L., Jiang, X., Guo, S., Zhang, H.-Q., Yin, Q.-Z., & Hisamitsu, T. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00462-7 · Cited by 20
DR4004, a putative 5-HT7 receptor antagonist, also has functional activity at the dopamine D2 receptor
Kogan, H. A., Marsden, C. A., & Fone, K. C. F. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02003-4 · Cited by 19
Recent Advances on the 5-HT5A, 5-HT6 and 5-HT7 Receptors
Shireman, B. T., Bonaventure, P., & Carruthers, N. I. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00002-x · Cited by 12
Effect of central serotonin depletion on 5‐HT receptor‐mediated vasomotor responses in the middle meningeal artery of anaesthetized rats
Martínez‐García, E., García‐Iglesias, B. B., & Terrón, J. A. (2009) · Autonomic and Autacoid Pharmacology · doi:10.1111/j.1474-8673.2009.00430.x · Cited by 7

Sorted by citations

Sleep disturbance as transdiagnostic: Consideration of neurobiological mechanisms
Harvey, A. G., Murray, G., Chandler, R. A., & Soehner, A. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.003 · Cited by 609
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 376
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Loebel, A. D., Cucchiaro, J. B., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. S. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070984 · Cited by 343
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
Suppes, T., Silva, R., Cucchiaro, J., Mao, Y., Targum, S., Streicher, C., Pikalov, A., & Loebel, A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060770 · Cited by 322

See all 253

Authors: Hedlund, P. B.
Affiliations: Scripps Research Institute (US)
Corresponding author: Hedlund, Peter B.
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2009-08-01
Volume: 206
Issue: 3
Pages: 345-354
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-009-1626-0
PMC: PMC2841472
OpenAlex: W1966819687
Cited by: 239
References: 92
Citations by year: 2026: 6 · 2025: 7 · 2024: 11 · 2023: 4 · 2022: 13 · 2021: 2 · 2020: 11 · 2019: 7 · 2018: 13 · 2017: 19 · 2016: 11 · 2015: 25 · 2014: 19 · 2013: 23 · 2012: 31
FWCI: 2.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (MH73923, R01MH073923)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: 5-HT7 receptor, serotonin, G protein-coupled receptors, depression, antidepressant-like effects, 5-HT7 receptor antagonists, amisulpride, anxiety, schizophrenia, epilepsy, migraine, pain, sleep, animal models of psychiatric disorders
MeSH terms: Animals, Antidepressive Agents, Disease Models, Animal, Humans, Nervous System Diseases, Receptors, Serotonin, Serotonin Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 5-HT7 receptor and disorders of the nervous system: an overview

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks